Protective effects of GYY4137 on spermatogenic function injury in varicocele rats
宁金卓,程帆,余伟民,饶婷,李浩勇,阮远,陈礼嘉,夏煜琦
DOI: https://doi.org/10.3760/cma.j.cn421213-20191202-01518
2020-01-01
Abstract:Objective:To observe the protective effects of GYY4137 on spermatogenic function injury in varicocele (VC) rats.Methods:Thirty-two adult male SD rats were randomly divided into 4 groups: sham operation group, sham operation+ GYY4137 group, VC group, VC+ GYY4137 group. Only abdominal cavity was opened in the sham operation group and sham operation+ GYY4137 group without ligation of the left renal vein. The left renal vein was ligated in the VC group and VC+ GYY4137 group to prepare the VC model. VC+ GYY4137 group and sham operation + GYY4137 group received intraperitoneal injection of GYY4137 [10 mg/(kg·d)]. HE staining was used to observe the pathological changes of testis. Malondialdehyde (MDA) contents and superoxide dismutase (SOD) activity were determined. Cell apoptosis index was detected by dUTP nick end labeling. The expression of B cell lymphoma/leukemia-2 associated X protein (bax) and cysteinyl aspartate-specific protease (Caspase)-3 in testis tissues was detected by immunohistochemistry and Western blotting.Results:The left testicular tissue showed desquamation of epithelial cells, disordered arrangement of spermatogenic cells in VC group. In VC+ GYY4137 group, the arrangement of spermatogenic cells was slightly disordered, and a few of spermatogenic cells were exfoliated. As compared with sham operation group [(1.86±0.23) nmol/gprot] and sham operation+ GYY4137 group [(1.83±0.22) nmol/gprot], MDA contents in VC group [(4.33±0.37) nmol/gprot] increased significantly (
t=9.820, 10.059,
P<0.05). As compared with VC group, MDA contents in VC+ GYY4137 group [(2.38±0.27) nmol/gprot] decreased significantly (
t=-7.374,
P<0.05). The SOD activity in VC group [(0.23±0.04) U/mgprot] was significantly lower than that in sham operation group [(0.81±0.06) U/mgprot] and sham operation+ GYY4137 group [(0.82±0.07) U/mgprot,
t=-9.757, -9. 926,
P<0.05]. The SOD activity in VC group increased after GYY4137 treatment [(0.62±0.06) U/mgprot,
t=9.368,
P<0.05]. TUNEL assay showed that there was apoptosis of less testicular spermatogenic cells in sham operation group and sham operation+ GYY4137 group [(3.89±0.45)%, (3.92±0.51)%], and the apoptotic cells increased significantly in VC group [(17.26±0.98)%,
P<0.05]. As compared with VC group, the apoptotic cells decreased significantly in VC+ GYY4137 group [(8.24±0.65)%,
P< 0.05]. Immunohistochemistry and Western blotting showed that the expression level of Caspase-3 and bax in VC group (0.41±0.04 and 0.59±0.06) was significantly higher than that in sham operation group (0.11±0.02, 0.19±0.03,
t=9.650, 9.097,
P<0.05) and sham operation+ GYY4137 group (0.12±0.02, 0.20±0.03,
t=9.327, 8.870,
P<0.05). As compared with VC group, the expression level of Caspase-3 and bax decreased significantly in VC+ GYY4137 group (0.21±0.03 and 0.34±0.04,
t=-6. 928, -6.005,
P<0.05).
Conclusion:GYY4137 reduces the level of oxidative stress and inhibits the apoptosis. Thus, it plays a protective role in spermatogenic function injury in VC rats.